Quercetin and Its Role in Chronic Diseases

被引:54
作者
Oboh, Ganiyu [1 ]
Ademosun, Ayokunle O. [1 ]
Ogunsuyi, Opeyemi B. [1 ]
机构
[1] Fed Univ Technol Akure, Dept Biochem, Funct Foods & Nutraceut Unit, PMB 704, Akure 340001, Ondo State, Nigeria
来源
DRUG DISCOVERY FROM MOTHER NATURE | 2016年 / 929卷
关键词
Quercetin; Flavonoids; Bioavailability; Degenerative diseases; Antioxidant; ANGIOTENSIN-CONVERTING ENZYME; BLOOD-PRESSURE; FLAVONOID QUERCETIN; ALPHA-GLUCOSIDASE; OXIDATIVE DAMAGE; FREE-RADICALS; RED WINE; ANTIOXIDANT; INHIBITION; RATS;
D O I
10.1007/978-3-319-41342-6_17
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quercetin, a member of the flavonoid class of polyphenol, is one of the most abundantly distributed flavonoids found in various food sources such as fruits, vegetables, nuts, wine and seeds. Quercetin and quercetin-rich foods have been reported to have wide range of health promoting effects, especially in the prevention and management of several diseases; however, the subject of its solubility and bioavailability has limited its use. This section will therefore, consider quercetin as a food-rich flavonoid, the various food sources, the limitations in its use and new approaches at improving its solubility and bioavailability. The therapeutic potentials of quercetin at the prevention/management of some degenerative diseases such as diabetes, hypertension and neurodegenerative diseases, as well as the underlying biochemical mechanisms such as free radical scavenging and enzyme inhibition will also be discussed.
引用
收藏
页码:377 / 387
页数:11
相关论文
共 69 条
[61]   Quercetin potentiates L-dopa reversal of drug-induced catalepsy in rats:: Possible COMT/MAO inhibition [J].
Singh, A ;
Naidu, PS ;
Kulkarni, SK .
PHARMACOLOGY, 2003, 68 (02) :81-88
[62]   Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites [J].
Spencer, JPE ;
Kuhnle, GGC ;
Williams, RJ ;
Rice-Evans, C .
BIOCHEMICAL JOURNAL, 2003, 372 (01) :173-181
[63]  
Stoclet JC, 1999, J PHYSIOL PHARMACOL, V50, P535
[64]   KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD [J].
Taler, Sandra J. ;
Agarwal, Rajiv ;
Bakris, George L. ;
Flynn, Joseph T. ;
Nilsson, Peter M. ;
Rahman, Mahboob ;
Sanders, Paul W. ;
Textor, Stephen C. ;
Weir, Matthew R. ;
Townsend, Raymond R. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 62 (02) :201-213
[65]   Nitric oxide formation and corresponding relaxation of porcine coronary arteries induced by plant phenols: Essential structural features [J].
Taubert, D ;
Berkels, R ;
Klaus, W ;
Roesen, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (05) :701-713
[66]   INHIBITION OF PLATELET-AGGREGATION BY SOME FLAVONOIDS [J].
TZENG, SH ;
KO, WC ;
KO, FN ;
TENG, CM .
THROMBOSIS RESEARCH, 1991, 64 (01) :91-100
[67]   Free radicals and antioxidants in normal physiological functions and human disease [J].
Valko, Marian ;
Leibfritz, Dieter ;
Moncol, Jan ;
Cronin, Mark T. D. ;
Mazur, Milan ;
Telser, Joshua .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (01) :44-84
[68]   Protection by quercetin and quercetin-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes [J].
Wilms, LC ;
Hollman, PCH ;
Boots, AW ;
Kleinjans, JCS .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2005, 582 (1-2) :155-162
[69]   Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway [J].
Youl, E. ;
Bardy, G. ;
Magous, R. ;
Cros, G. ;
Sejalon, F. ;
Virsolvy, A. ;
Richard, S. ;
Quignard, J. F. ;
Gross, R. ;
Petit, P. ;
Bataille, D. ;
Oiry, C. .
BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (04) :799-814